sulfamethoxazole has been researched along with atovaquone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Hughes, WT; Killmar, JT; Oz, HS | 1 |
| Ager, AL; Canfield, CJ; Jacobus, DP; Lewis, NJ; Milhous, WK; Rossan, RN; Sweeney, TR | 1 |
| Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Yeo, AE | 1 |
| Lakritz, J; Marsh, AE; Mullins, AL | 1 |
| Miller, JL; Trepanier, LA | 1 |
| Androudi, S; Bhaila, I; Fiore, T; Iaccheri, B; Janjua, S; Papadaki, T; Stephen Foster, C | 1 |
11 other study(ies) available for sulfamethoxazole and atovaquone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Naphthoquinones; Pentamidine; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
Topics: Administration, Oral; Animals; Antimalarials; Aotus trivirgatus; Atovaquone; Drug Synergism; Folic Acid Antagonists; Imides; Injections, Subcutaneous; Malaria, Falciparum; Mice; Naphthoquinones; Phenyl Ethers; Plasmodium falciparum; Proguanil; Sulfamethoxazole; Triazines | 1993 |
In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Atovaquone; Cells, Cultured; Dapsone; Drug Synergism; Folic Acid Antagonists; Humans; Lung; Macrolides; Microbial Sensitivity Tests; Naphthoquinones; Pneumocystis; Sulfamethoxazole | 1997 |
Direct comparison of antimalarial activity among PS-15 combination therapies by bioassay of serum samples from treated Saimiri sciureus.
Topics: Animals; Antimalarials; Atovaquone; Biological Assay; Dapsone; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil; Regression Analysis; Saimiri; Sulfamethoxazole | 1997 |
In vitro quantitative analysis of (3)H-uracil incorporation by Sarcocytis neurona to determine efficacy of anti-protozoal agents.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Cattle; Deer; DNA Replication; Glycine; Glyphosate; Herbicides; Male; Naphthoquinones; Nitriles; Pyrimethamine; Reproduction; Sarcocystis; Sulfadiazine; Sulfamethoxazole; Tetracycline; Triazines; Tritium; Uracil | 2001 |
Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation.
Topics: Adult; Antiprotozoal Agents; Aryl Hydrocarbon Hydroxylases; Atovaquone; Blood Proteins; Cells, Cultured; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Microsomes, Liver; Middle Aged; Naphthoquinones; Protein Binding; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Sulfamethoxazole | 2002 |
Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
Topics: Adolescent; Adult; Atovaquone; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; Gastrointestinal Diseases; Humans; Male; Medical Records; Middle Aged; Pyrimethamine; Retrospective Studies; Sulfadiazine; Sulfamethoxazole; Toxoplasmosis, Ocular; Trimethoprim; Vitreous Body; Young Adult | 2008 |